Pegloticase quickly lowers serum urate levels and relieves pain in a substantial proportion of patients with severe, treatment-refractory gout, according to phase III clinical trial results presented Sunday at the American College of Rheumatology Annual Scientific Meeting in San Francisco. Reuters Health Information
How safe is adalimumab for patients with ankylosing spondylitis or psoriatic arthritis who had previously been treated with anti-TNF agents? This new study looks at the data. Arthritis Research & Therapy
In most patients with rheumatoid arthritis, targeting a combination of DMARDs to remission with tight clinical controls results in low radiologic progression. Medscape Medical News
